On May 17, 2021 President Biden Office has partnered that by the end of June, the U.S. will provide 80 million doses of the COVID-19 vaccine for international use. Sixty million of these doses IMMINENT to make a U.S.-owned dose of the Oxford / AstraZeneca vaccine (enough to vaccinate 30 million people), which has not yet been approved by the U.S. but has been approved by many countries. An additional 20 million U.S. owners dose from a ingredients of the Pfizer, Moderna, and Johnson and Johnson vaccines (while the exact combination of doses for each has not been announced, they could be quite enough vaccines for an additional 10-20 million people).
Prior to this point, the U.S. provided 4 million doses of AstraZeneca to Canada and Mexico (via a “loans”), So 80 million doses would represent a significant increase in U.S. vaccine donations and make the U.S. the largest contributing single country providing poor doses of the vaccine in worldwide (see Photo) In addition, the US also spends $ 4 billion on COVAX, the international partnership for the procurement and distribution of the COVID-19 vaccine managed by the Gavi Alliance, CEPI, and the World Health Organization, which also makes the U.S. the largest provider of this effort. * In addition, vaccine production and manufacturing continues to lag and is a major provider of vaccines worldwide. Office has partnered it will not export any additional doses until the end of this year, highlighting the importance of countries donating doses in the near future.
While others have praised the latest announcement of US donations as a significant development, some say the US can do a lot labi pa, pointing to the large supply of doses being increased in the U.S. and the slowing demand for vaccines in the country. We ask that the U.S. pledge of 80 million doses be placed in further context, looking at what is represented in relation to the current landscape:
- Almost 3 times the number of doses promised by the next largest donor in the country, France; **
- 56% of donated doses from all other governments combined;
- 115% of the total number of doses already brought through COVAX until May 20;
- Less than 2% of the number of doses needed to vaccinate all people in low -and -middle -income countries (LMICs);
- 8-16% of the number of doses sufficient to vaccinate the highest risk groups of LMICs-health care workers and the elderly over 65;
- 29% of total accumulated vaccine doses administered in the US (until May 18).
- picture: US pledge 80 million doses compared to pledges from other donating governments
The world is still the same not the same about access to vaccines across regions and income groups, with estimates that some low-income countries may not vaccinate most of their adult populations in a year or so. moreover, even if many high -income countries have approached or exceeded this milestone. Therefore, donated doses can help speed up vaccinations around the world, provided that doses can be given efficiently and managed effectively in countries that need them. Currently the US promises to provide more doses than any other country and has made the largest contribution to COVAX to date. However, the U.S. effort only represents a fraction of what is needed to vaccinate everyone, raising challenging questions about how to access COVID-19 vaccines. up and what the timeline is, and what the role should be of high -income countries going forward.
|Notes and Sources|
|* Information about the price of vaccine doses paid for by COVAX to manufacturers is not available, so it is not known how many COVAX doses will support the U.S. contribution.
** Donors promised to provide COVID-19 doses at different time frames. For example, France promises to provide 30 million doses by the end of 2021, while the US promises to provide 80 million doses by the end of June.
Data on COVID-19 vaccine dose donations were obtained from the UNICEF COVID-19 Vaccine Market Dashboard and other public news sources. Included in the data are donations made bilaterally as well as through COVAX. Included with the data are donations with confirmed delivery status and pledges.
COVAX delivery data were obtained from the UNICEF COVID-19 Vaccine Market Dashboard.
Population data for adults over 65 years in low -income countries, as defined by the World Bank, are obtained from the United Nations. Prospects for the world’s population using estimates for 2020. Data on health workers for countries with low and half incomes are obtained from the World Health Organization National Health Workforce Account Data Portal, limits the data to the estimated number of physicians, nurses, and midwives under the age of 65 for the most recent data year available.
U.S. vaccine administration data obtained from the Centers for Disease Control and Prevention’s COVID Data Tracker.